Raymond James Trust N.A. Buys 829 Shares of Centene Co. (NYSE:CNC)

Raymond James Trust N.A. grew its position in shares of Centene Co. (NYSE:CNC) by 1.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 73,188 shares of the company’s stock after buying an additional 829 shares during the quarter. Raymond James Trust N.A.’s holdings in Centene were worth $5,510,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. Park Place Capital Corp boosted its stake in shares of Centene by 1,190.0% during the 3rd quarter. Park Place Capital Corp now owns 387 shares of the company’s stock worth $29,000 after acquiring an additional 357 shares during the last quarter. WR Wealth Planners LLC increased its holdings in Centene by 41.4% in the 2nd quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock worth $31,000 after acquiring an additional 137 shares in the last quarter. Chris Bulman Inc bought a new stake in Centene during the 2nd quarter worth approximately $33,000. Riverview Trust Co lifted its holdings in Centene by 154.6% during the second quarter. Riverview Trust Co now owns 527 shares of the company’s stock valued at $35,000 after purchasing an additional 320 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. bought a new position in shares of Centene in the second quarter worth approximately $36,000. Hedge funds and other institutional investors own 93.63% of the company’s stock.

Insider Buying and Selling at Centene

In other news, CEO Sarah London bought 4,117 shares of Centene stock in a transaction dated Friday, November 8th. The shares were acquired at an average price of $60.80 per share, with a total value of $250,313.60. Following the completion of the purchase, the chief executive officer now owns 667,229 shares in the company, valued at $40,567,523.20. The trade was a 0.62 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Andrew Lynn Asher purchased 17,200 shares of the company’s stock in a transaction that occurred on Wednesday, November 13th. The shares were purchased at an average cost of $58.14 per share, with a total value of $1,000,008.00. Following the completion of the purchase, the chief financial officer now owns 486,847 shares in the company, valued at $28,305,284.58. This trade represents a 3.66 % increase in their position. The disclosure for this purchase can be found here. Company insiders own 0.33% of the company’s stock.

Centene Stock Performance

Centene stock opened at $60.37 on Friday. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.64. Centene Co. has a twelve month low of $57.20 and a twelve month high of $81.42. The company’s 50-day moving average price is $66.68 and its 200-day moving average price is $70.50. The company has a market cap of $30.48 billion, a PE ratio of 10.48, a price-to-earnings-growth ratio of 0.79 and a beta of 0.49.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Oppenheimer lowered their target price on shares of Centene from $110.00 to $95.00 and set an “outperform” rating on the stock in a research note on Monday, July 29th. Stephens restated an “equal weight” rating and issued a $78.00 price objective on shares of Centene in a research report on Monday, August 5th. Wells Fargo & Company cut their target price on Centene from $91.00 to $90.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. Robert W. Baird lowered their price target on Centene from $83.00 to $66.00 and set a “neutral” rating on the stock in a report on Friday, October 25th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $90.00 price objective on shares of Centene in a report on Tuesday, October 1st. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, Centene presently has an average rating of “Moderate Buy” and an average price target of $83.92.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.